Abdominal Radiology – Study using texture analysis (TexRAD) of the liver at MDCT for assessing hepatic fibrosis – Feedback plc
Abdominal Radiology – Study using texture analysis of the liver at MDCT for assessing hepatic fibrosis By Lubner MG, et al. Abdom Radiol (NY). 2017. Source PubMed. PURPOSE: To evaluate CT texture analysis (CTTA) for staging of hepatic fibrosis (stages F0-F4) METHODS: Quantitative texture analysis (QTA) of the liver was performed on abdominal MDCT scans […]
Feedback (FDBK) – Re Media Articles
Feedback plc (AIM: FDBK), the medical imaging software company, is pleased to update shareholders following the recent media articles regarding the use of multi-parametric MRI scans for the diagnosis of prostate cancer. It was widely reported in the national press and on the BBC website on 20 January 2017 that a trial led by Mr […]
Feedback PLC (FDBK) – Attendance at RSNA 2016
Feedback plc (AIM: FDBK), the medical imaging software company, is pleased to provide an update on the Company’s attendance at the 102nd Scientific Assembly and Annual Meeting of the Radiological Society of North America to be held 27 November – 2 December 2016, in Chicago, Illinois, USA. (“RSNA 2016”). This is the premier global event for […]
Feedback PLC – ICENI Centre & ISLCRS study to investigate whether textural features of rectal cancer on Magnetic Resonance can predict long term survival
Magnetic resonance based texture parameters as potential imaging biomarkers for predicting long term survival in locally advanced rectal cancer patients. Omer Jalil, Asim Afaq, Balaji Ganeshan, Uday Patel, Raymond Endozo, Darren Boone, Ashley Groves, David Humber, Tan Arulampalam ICENI Centre Colchester University Hospital Colchester CO4 5JL Introduction: Heterogeneity is a well-known feature of malignancy and […]
Feedback Plc – Presentation of Study Results
Feedback Plc – Presentation of Study Results On July 20th 2015, Feedback plc announced the successful completion of a large evaluation of TexRAD CT texture analysis (CTTA) as a pre-therapy imaging biomarker in 241 metastatic renal (kidney) cell cancer (m-RCC) patients treated with anti-angiogenic therapy (AAT – drugs that block cancer blood-vessel growth). The research […]
Feedback (FDBK) – Exercise of Options
Feedback plc (FDBK), the medical imaging software company, has received notification of an exercise of options over 1.6 million new ordinary shares by an employee under its EMI share option scheme. The exercise price of the options is 1.25 pence each. The New Ordinary Shares will rank pari passu with the existing ordinary shares and […]
Feedback PLC – Issue of equity
Feedback plc (FDBK), the medical imaging software company, announces that it has issued and allotted 216,000 new ordinary shares of 0.25 pence each at a price of 1.25 pence per ordinary share to Brand UK Limited, the Company’s PR adviser, in lieu of fees for professional services provided to the Company. The New Ordinary Shares will rank […]
Feedback PLC – Dr Balaji Ganeshan interviewed by Justin Waite on the ADVFN podcast
Feedback PLC – Chief Scientist & News Business Officer Dr Balaji Ganeshan is interviewed by Justin Waite on the ADVFN podcast. The interview can be found 20 minutes & 30 seconds into the podcast, click here to listen to the podcast.
Feedback PLC announces the first server sale of TexRAD in Canada
Feedback plc (FDBK), the medical imaging software company, is pleased to announce its first server sale for research purposes in Canada of the Group’s TexRAD texture analysis software. The software will be installed in the Department of Diagnostic Radiology at the McGill University Health Centre’s Montreal General Hospital site. The MUHC is one of the […]
Feedback PLC – Statement re Share Price Movement
The Board of Feedback plc (FDBK), the medical imaging software company, notes the increase in the Company’s share price, trading volume and speculation on bulletin boards. As announced on the 3 June 2015, the Company completed a successful placing with Director participation which has attracted positive media comment however the Board can confirm they know […]